DE | EN

Dr. med. Richard Vollenberg

Aktuelle Zugehörigkeiten

Medizinische Klinik B (Med B)

Publikationen

SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Lorentzen, E. U.; Vollenberg, R.; Neddermeyer, R.; Schoefbaenker, M.; Hrincius, E. R.; Ludwig, S.; Tepasse, P.-R.; Kuehn, J. E. (2025) In: Vaccines, 13(6), 595. Forschungsartikel (Zeitschrift)
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Schoefbaenker, M; Günther, T; Lorentzen, EU; Romberg, M-L; Hennies, MT; Neddermeyer, R; Müller, MM; Mellmann, A; Bojarzyn, CR; Lenz, G; Stelljes, M; Hrincius, ER; Vollenberg, R; Ludwig, S; Tepasse, P-R; Kühn, JE (2024) In: PLoS Pathogens, 20(10). Forschungsartikel (Zeitschrift)
Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis Bokemeyer, Arne; Buskermolen, Joost; Ketelhut, Steffi; Tepasse, Phil-Robin; Vollenberg, Richard; Trebicka, Jonel; Schmidt, Hartmut. H.; Vieth, Michael; Bettenworth, Dominik; Kemper, Björn , (2023) In: Journal of Clinical Medicine, 12(12), 4067. Forschungsartikel (Zeitschrift)
Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study Vollenberg R, Tepasse PR, Lorentzen E, Nowacki T (2022) In: Journal of personalized medicine, 12. Forschungsartikel (Zeitschrift)
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2 Vollenberg R, Tepasse P-R, Kühn JE, Hennies M, Strauss, M Rennebaum F, Schomacher T, Boeckel G, Lorentzen E, Bokemeyer A, Nowacki TM* (*equally contributed) (2022) In: Biomedicines, 10(171). Forschungsartikel (Zeitschrift)

Alle Publikationen anzeigen